Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03866278 · ClinicalTrials.gov registry record
Characterizing the Electroencephalogram Signature of Fentanyl During Induction of General Anesthesia
A clinical trial, sponsored by Massachusetts General Hospital.
- Completed
- Registry status
- 31
- Enrollment target
NCT03866278: Completed study, sponsored by Massachusetts General Hospital.
NCT03866278 is a clinical trial that has completed, run by Massachusetts General Hospital. The registered enrollment target is 31 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03866278 has completed, sponsored by Massachusetts General Hospital.
- COMPLETED
- Registry status
- 31 participants
- Enrollment target
Study Summary
While historically anesthesiologists rely on pharmacokinetics to track the loss of consciousness, new research in anesthesiology has identified the salient features of the electroencephalogram (EEG) that correlate to states of sedation and unconsciousness induced by different anesthetic drugs. While the EEG features of many sedative-hypnotic anesthetics have been well- characterized, the opioid analgesic drugs have not been analyzed in detail in this way. A characterization of the EEG signatures of opioid analgesic drugs could be useful in monitoring and titrating the effects of these drugs.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 31 participants |
| Start Date | 2018-06-27 |
| Est. Completion | 2022-08-30 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03866278
The ClinicalTrials.gov registry entry for NCT03866278 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 31 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Massachusetts General Hospital, which has 2,032 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT03866278 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03866278 about?
NCT03866278 is a clinical study titled "Characterizing the Electroencephalogram Signature of Fentanyl During Induction of General Anesthesia". While historically anesthesiologists rely on pharmacokinetics to track the loss of consciousness, new research in anesthesiology has identified the salient features of the electroencephalogram (EEG) that correlate to states of sedation and unconsciousness induced by different anesthetic drugs. While...
What is the current status of trial NCT03866278?
This trial is currently completed. The enrollment target is 31 participants. The study started on 2018-06-27. Estimated completion is 2022-08-30.
Who is sponsoring clinical trial NCT03866278?
This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.